+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis by Product Type (Instruments, Services), by Sample Type (Blood, NPS), by Application, by Technology, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 162 Pages
  • September 2022
  • Region: Global
  • Grand View Research
  • ID: 5665116
Description Jump to:
The global infectious respiratory disease diagnostics market size is expected to reach USD 43.6 billion by 2030, registering a CAGR of -1.8% over the forecast period. The decline in market size is majorly attributed to the decline in COVID-19 testing. However, the market without the impact of COVID-19 is expected to grow over the forecast years. The growth can be attributed to an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & nonprofit organizations to introduce novel & innovative products to address the increasing demand. For instance, the global investment in tuberculosis R&D reached USD 915 million, and around USD 401 million was spent by the U.S. government on TB research in 2020.

During the forecast period, the global industry is expected to be driven by the rising incidence of infectious respiratory disorders, such as tuberculosis, RSV, and influenza. According to the UN, pneumonia affects around 4.2 million people every year. Key players are developing innovative techniques to improve production for meeting the growing demand in diagnostics and consumables for the diagnosis of infectious diseases. For instance, OPT Industries Inc. has introduced InstaSwab by utilizing the 3D printing system to address supply shortages of sample collection kits due to the COVID-19 pandemic. These swabs are made of woven lattices to absorb and release more fluid than conventional swabs. Companies are advancing their diagnosis products by using new techniques to gain target-specific and accurate results.

Canon Inc. announced the development of a built-in AEC assistance for digital X-rays in March 2021. The X-ray image sensor enables users to perform picture production and real-time detection of images corresponding to emitted X-rays. Furthermore, in May 2021, the University of California developed an ultrasensitive molecular test to identify the presence of SARS-CoV-2 and influenza A antigens using chip technology. In addition, companies are also launching multiplex tests for the simultaneous diagnosis of RSV, influenza, and COVID-19 respiratory diseases. RT-PCR tests are considered the gold standard for the diagnosis of COVID-19 in patients. However, high prices associated with molecular tests are one of the major factors impeding this market.

The lack of comparable products is another reason for hiked prices. This problem is further compounded by the significant variations in prices for different applications of each molecular diagnostic product. Companies are adopting strategies, such as new product launches and partnerships, to increase the penetration of infectious respiratory disease diagnostics products. For instance, in August 2021, Thermo Fisher Scientific Inc. received EUA for the introduction of two COVID-19 diagnostic products, TaqPath COVID-19 RNase P Combo Kit and TaqPath COVID-19 Fast PCR Combo Kit, in the U.S. market.

Infectious Respiratory Disease Diagnostics Market Report Highlights

  • In 2021, the consumables segment accounted for the largest revenue share and is anticipated to maintain its dominance over the forecast period owing to high testing rates for the diagnosis of COVID-19 and the commercialization of multiple assays in recent years
  • Molecular diagnostics accounted for the highest revenue share in 2021, owing to the increasing use of PCR technology for COVID-19 diagnosis
  • The nasopharyngeal swabs sample type segment accounted for the highest revenue share in 2021 owing to high usage in COVID-19 diagnosis
  • The COVID-19 application segment led the industry in 2021 due to factors, such as high incidence rate, increasing product approvals, and high R&D initiatives for launching innovative products
  • Tuberculosis is expected to exhibit the fastest CAGR over the forecast period owing to increasing government focus and R&D funding for the development of diagnostics
  • Asia Pacific is expected to experience the fastest growth over the forecast period owing to an increase in penetration of IVD products, rise in disposable income, and high prevalence of tuberculosis in underdeveloped countries


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Infectious Respiratory Disease Diagnostics Market Variables, Trends, and Scope
3.1 Penetration and Growth Prospect Mapping
3.2 Market Driver analysis
3.2.1 High Prevalence Of Infectious Respiratory Diseases Globally
3.2.2 Technological Advancement In Respiratory Disease Testing
3.2.3 Rising R&D Investments In Respiratory Disease Testing
3.3 Market Restraint Analysis
3.3.1 High Prices Of Diagnostic Products
3.3.2 Presence Of Ambiguous Regulatory Framework
3.4 Market Opportunity Analysis
3.4.1 Increasing Adoption Of Self-Testing Products And Point-Of-Care Products
3.4.2 Increasing Focus On Introducing Multiplex Pcr
3.5 Covid Impact Analysis
3.6 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
3.7 Industry Analysis - Porter’s
3.8 Multiplex testing in infectious respiratory disease testing, market opportunity
Chapter 4 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Product Type, 2018 - 2030 (USD Million)
4.1 Definitions and Scope
4.2 Infectious Respiratory Disease Diagnostics Market: Product Type Movement Analysis
4.3 Instruments
4.3.1 Instruments Market, 2018 - 2030 (USD Million)
4.3.2 Imaging Tests
4.3.2.1 Imaging Tests Market, 2018 - 2030 (USD Million)
4.3.3 Respiratory Measurement Devices
4.3.3.1 Respiratory Measurement Devices Market, 2018 - 2030 (USD Million)
4.3.4 Other Instruments
4.3.4.1 Other Instruments Market, 2018 - 2030 (USD Million)
4.4 Consumables
4.4.1 Consumables Market, 2018 - 2030 (USD Million)
4.5 Services
4.5.1 Services Market, 2018 - 2030 (USD Million)
Chapter 5 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Sample Type, 2018 - 2030 (USD Million)
5.1 Definitions & Scope
5.2 Infectious Respiratory Disease Diagnostics Market: Sample Type Movement Analysis
5.3 Saliva
5.3.1 Saliva Market, 2018 - 2030 (USD Million)
5.4 Nasopharyngeal Swabs (Nps)
5.4.1 Nasopharyngeal Swabs (Nps) Market, 2018 - 2030 (USD Million)
5.5 Anterior Nasal Region
5.5.1 Anterior Nasal Region Market, 2018 - 2030 (USD Million)
5.6 Blood
5.6.1 Blood Market, 2018 - 2030 (USD Million)
5.7 Others
5.7.1 Others Market, 2018 - 2030 (USD Million)
Chapter 6 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Technology, 2018 - 2030 (USD Million)
6.1 Definitions and Scope
6.2 Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis
6.3 Immunoassay
6.3.1 Immunoassay Market, 2018 - 2030 (USD Million)
6.4 Molecular Diagnostics
6.4.1 Molecular Diagnostics Market, 2018 - 2030 (USD Million)
6.5 Microbiology
6.5.1 Microbiology Market, 2018 - 2030 (USD Million)
6.6 Other Technologies
6.6.1 Other Technologies Market, 2018 - 2030 (USD Million)
Chapter 7 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Application, 2018 - 2030 (USD Million) (‘000)
7.1 Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis
7.2 COVID-19
7.2.1 Covid-19 Market, 2018 - 2030 (USD Million)
7.2.2 Covid-19 Market, 2018 - 2030 (Volume ‘000)
7.3 Influenza
7.3.1 Influenza Market, 2018 - 2030 (USD Million)
7.3.2 Influenza Market, 2018 - 2030 (Volume ‘000)
7.4 Respiratory Syncytial Virus
7.4.1 Respiratory Syncytial Virus Market, 2018 - 2030 (USD Million)
7.4.2 Respiratory Syncytial Virus Market, 2018 - 2030 (Volume ‘000)
7.5 Tuberculosis
7.5.1 Tuberculosis Market, 2018 - 2030 (USD Million)
7.5.2 Tuberculosis Market, 2018 - 2030 (Volume ‘000)
7.6 Streptococcus Testing
7.6.1 Streptococcus Testing Market, 2018 - 2030 (USD Million)
7.6.2 Streptococcus Testing Market, 2018 - 2030 (Volume ‘000)
7.7 Other Respiratory Disease Testing
7.7.1 Other Respiratory Disease Testing Market, 2018 - 2030 (USD Million)
7.7.2 Other Respiratory Disease Testing Market, 2018 - 2030 (Volume ‘000)
Chapter 8 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by End-use, 2018 - 2030 (USD Million)
8.1 Infectious Respiratory Disease Diagnostics Market: End-use Movement Analysis
8.2 Hospitals
8.2.1 Hospitals Market, 2018 - 2030 (USD Million)
8.3 Diagnostic Laboratories
8.3.1 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
8.4 Physician Offices
8.4.1 Physician Offices Market, 2018 - 2030 (USD Million)
8.5 Other End-Users
8.5.1 Other End-Users Market, 2018 - 2030 (USD Million)
Chapter 9 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)
9.1 Market Share Analysis
9.2 Regional Market Share Analysis, 2021 & 2030
9.3 Regional Market Snapshot
9.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
9.4.1 North America
9.4.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
9.4.1.2 U.S.
9.4.1.2.1 U.S. Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.1.3 Canada
9.4.1.3.1 Canada Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2 Europe
9.4.2.1 Europe Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.2 U.K.
9.4.2.2.1 U.K. Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.3 Germany
9.4.2.3.1 Germany Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.4 Spain
9.4.2.4.1 Spain Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.5 France
9.4.2.5.1 France Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.6 Italy
9.4.2.6.1 Italy Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.7 Russia
9.4.2.7.1 Russia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3 Asia Pacific
9.4.3.1 Asia Pacific Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.2 Japan
9.4.3.2.1 Japan Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.3 China
9.4.3.3.1 China Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.4 India
9.4.3.4.1 India Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.5 South Korea
9.4.3.5.1 South Korea Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.6 Australia
9.4.3.6.1 Australia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.7 Singapore
9.4.3.7.1 Singapore Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4 Latin America
9.4.4.1 Latin America Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4.2 Brazil
9.4.4.2.1 Brazil Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4.3 Mexico
9.4.4.3.1 Mexico Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4.4 Argentina
9.4.4.4.1 Argentina Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5 MEA
9.4.5.1 MEA Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5.2 South Africa
9.4.5.2.1 South Africa Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5.3 Saudi Arabia
9.4.5.3.1 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5.4 UAE
9.4.5.4.1 UAE Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
Chapter 10 Infectious Respiratory Disease Diagnostics Market: Competitive Analysis
10.1 Recent Developments and Impact Analysis, by Key Market Participants
10.1.1 New Product Launches
10.1.2 Mergers And Acquisitions
10.1.3 Partnerships And Strategic Collaboration
10.1.4 Conferences And Campaigns
10.2 Company Categorization
10.2.1 Innovators
10.2.2 Market Leaders
10.2.3 Heat Map Analysis
10.3 Vendor Landscape
10.3.1 List Of Key Distributors And Channel Partners
10.3.2 Key Customers
10.4 Key Company Market Share Analysis, 2021
10.5 Public Companies
10.5.1 Company Market Position Analysis
10.5.2 Company Market Position Analysis
10.5.3 Competitive Dashboard Analysis
10.5.3.1 Market Differentiators
10.6 Private Companies
10.6.1 List Of Key Emerging Companies
10.6.2 Regional Network Map
10.7 Company Profiles
10.7.1 ABBOTT
10.7.1.1 Company overview
10.7.1.2 Financial performance
10.7.1.3 Product benchmarking
10.7.1.4 Strategic initiatives
10.7.2 THERMO FISHER SCIENTIFIC, INC.
10.7.2.1 Company overview
10.7.2.2 Financial performance
10.7.2.3 Product benchmarking
10.7.2.4 Strategic initiatives
10.7.3 KONINKLIJKE PHILIPS N.V.
10.7.3.1 Company overview
10.7.3.2 Financial performance
10.7.3.3 Product benchmarking
10.7.3.4 Strategic initiatives
10.7.4 F. HOFFMANN-LA ROCHE LTD
10.7.4.1 Company overview
10.7.4.2 Financial performance
10.7.4.3 Product benchmarking
10.7.4.4 Strategic initiatives
10.7.5 BIOMÉRIEUX SA
10.7.5.1 Company overview
10.7.5.2 Financial performance
10.7.5.3 Product benchmarking
10.7.5.4 Strategic initiatives
10.7.6 BIO-RAD LABORATORIES, INC.
10.7.6.1 Company overview
10.7.6.2 Financial performance
10.7.6.3 Product benchmarking
10.7.6.4 Strategic initiatives
10.7.7 QUIDEL CORPORATION
10.7.7.1 Company overview
10.7.7.2 Financial performance
10.7.7.3 Product benchmarking
10.7.7.4 Strategic initiatives
10.7.8 CEPHEID (DANAHER)
10.7.8.1 Company Overview
10.7.8.2 Financial Performance
10.7.8.3 Product Benchmarking
10.7.8.4 Strategic Initiatives
10.7.9 QIAGEN
10.7.9.1 Company Overview
10.7.9.2 Financial Performance
10.7.9.3 Product Benchmarking
10.7.9.4 Strategic Initiatives
10.7.10 SIEMENS HEALTHCARE GMBH
10.7.10.1 Company Overview
10.7.10.2 Financial Performance
10.7.10.3 Product Benchmarking
10.7.10.4 Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviation
Table 3 List of key distributors
Table 4 List of other companies
Table 5 List of key emerging companies / technology disruptors/innovators
Table 6 North America Infectious Respiratory Disease Diagnostics Market, By Country, 2018 - 2030 (USD Million)
Table 7 North America Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 8 North America Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 9 North America Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 10 North America Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 11 North America Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 12 U.S. Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 13 U.S. Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 14 U.S. Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 15 U.S. Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 16 U.S. Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 17 Canada Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 18 Canada Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 19 Canada Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 20 Canada Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 21 Canada Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 22 Europe Infectious Respiratory Disease Diagnostics Market, By Country, 2018 - 2030 (USD Million)
Table 23 Europe Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 24 Europe Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 25 Europe Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 26 Europe Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 27 Europe Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 28 U.K. Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 29 U.K. Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 30 U.K. Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 31 U.K. Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 32 U.K. Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 33 Germany Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 34 Germany Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 35 Germany Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 36 Germany Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 37 Germany Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 38 France Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 39 France Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 40 France Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 41 France Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 42 France Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 43 Spain Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 44 Spain Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 45 Spain Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 46 Spain Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million)
Table 47 Spain Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 48 Italy Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 49 Italy Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 50 Italy Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 51 Italy Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 52 Italy Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 53 Russia Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 54 Russia Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 55 Russia Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 56 Russia Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 57 Russia Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 62 Asia Pacific Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 63 Japan Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 64 Japan Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 65 Japan Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 66 Japan Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 67 Japan Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 68 China Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 69 China Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 70 China Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 71 China Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 72 China Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 73 India Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 74 India Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 75 India Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 76 India Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 77 India Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 78 Australia Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 79 Australia Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 80 Australia Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 81 Australia Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 82 Australia Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 83 South Korea Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 84 South Korea Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 85 South Korea Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 86 South Korea Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 87 South Korea Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 88 Singapore Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 89 Singapore Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 90 Singapore Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 91 Singapore Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 92 Singapore Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 93 Latin America Infectious Respiratory Disease Diagnostics Market, By Country, 2018 - 2030 (USD Million)
Table 94 Latin America Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 95 Latin America Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 96 Latin America Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 97 Latin America Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 98 Latin America Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 99 Brazil Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 100 Brazil Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 101 Brazil Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 102 Brazil Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 103 Brazil Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 104 Mexico Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 105 Mexico Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 106 Mexico Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 107 Mexico Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 108 Mexico Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 109 Argentina Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 110 Argentina Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 111 Argentina Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 112 Argentina Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 113 Argentina Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 114 MEA Infectious Respiratory Disease Diagnostics Market, By Country, 2018 - 2030 (USD Million)
Table 115 MEA Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 116 MEA Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 117 MEA Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 118 MEA Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 119 MEA Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 120 South Africa Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 121 South Africa Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 122 South Africa Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 123 South Africa Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 124 South Africa Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 125 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 126 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 127 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 128 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 129 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
Table 130 UAE Infectious Respiratory Disease Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
Table 131 UAE Infectious Respiratory Disease Diagnostics Market, By Sample Type, 2018 - 2030 (USD Million)
Table 132 UAE Infectious Respiratory Disease Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 133 UAE Infectious Respiratory Disease Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Volume in Thousands)
Table 134 UAE Infectious Respiratory Disease Diagnostics Market, By End-Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Infectious respiratory disease diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2021)
Fig. 10 Penetration and growth prospect mapping
Fig. 11 Infectious respiratory disease diagnostics market driver impact
Fig. 12 Research funding for TB diagnostics in 2019
Fig. 13 Infectious respiratory disease diagnostics market restraint impact
Fig. 14 Infectious respiratory disease diagnostics market opportunity impact
Fig. 15 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 16 Porter’s Five Forces Analysis
Fig. 17 Infectious respiratory disease diagnostics product type outlook: Key takeaways
Fig. 18 Infectious respiratory disease diagnostics market: Product type movement analysis (USD million)
Fig. 19 Instruments market, 2018 - 2030 (USD million)
Fig. 20 Imaging tests market, 2018 - 2030 (USD million)
Fig. 21 Respiratory measurement devices market, 2018 - 2030 (USD million)
Fig. 22 Other instruments market, 2018 - 2030 (USD million)
Fig. 23 Consumables market, 2018 - 2030 (USD million)
Fig. 24 Services market, 2018 - 2030 (USD million)
Fig. 25 Infectious respiratory disease diagnostics Sample type outlook: Key takeaways
Fig. 26 Infectious respiratory disease diagnostics market: Sample type movement analysis (USD million)
Fig. 27 Saliva market, 2018 - 2030 (USD million)
Fig. 28 Nasopharyngeal swabs (NPS) market, 2018 - 2030 (USD million)
Fig. 29 Anterior nasal region market, 2018 - 2030 (USD million)
Fig. 30 Blood market, 2018 - 2030 (USD million)
Fig. 31 Others market, 2018 - 2030 (USD million)
Fig. 32 Infectious respiratory disease diagnostics technology outlook: Key takeaways
Fig. 33 Infectious respiratory disease diagnostics market: Technology movement analysis (USD million)
Fig. 34 Immunoassay market, 2018 - 2030 (USD million)
Fig. 35 Molecular diagnostics market, 2018 - 2030 (USD million)
Fig. 36 Microbiology market, 2018 - 2030 (USD million)
Fig. 37 Other technologies market, 2018 - 2030 (USD million)
Fig. 38 Infectious respiratory disease diagnostics application outlook: Key takeaways
Fig. 39 Infectious respiratory disease diagnostics application outlook: Key takeaways
Fig. 40 Infectious respiratory disease diagnostics market: Application movement analysis (USD million)
Fig. 41 Infectious respiratory disease diagnostics market: Application movement analysis (Volume, ‘000)
Fig. 42 COVID-19 market, 2018 - 2030 (USD million)
Fig. 43 COVID-19 market, 2018 - 2030 (Volume ‘000)
Fig. 44 Influenza market, 2018 - 2030 (USD million)
Fig. 45 Influenza market, 2018 - 2030 (Volume ‘000)
Fig. 46 Respiratory syncytial virus market, 2018 - 2030 (USD million)
Fig. 47 Respiratory syncytial virus market, 2018 - 2030 (Volume ‘000)
Fig. 48 Tuberculosis market, 2018 - 2030 (USD million)
Fig. 49 Tuberculosis market, 2018 - 2030 (Volume ‘000)
Fig. 50 Streptococcus testing market, 2018 - 2030 (USD million)
Fig. 51 Streptococcus testing market, 2018 - 2030 (Volume ‘000)
Fig. 52 Other respiratory disease testing market, 2018 - 2030 (USD million)
Fig. 53 Other respiratory disease testing market, 2018 - 2030 (Volume ‘000)
Fig. 54 Infectious respiratory disease diagnostics end-use outlook: Key takeaways
Fig. 55 Infectious respiratory disease diagnostics market: End-use movement analysis (USD million)
Fig. 56 Hospitals market, 2018 - 2030 (USD million)
Fig. 57 Diagnostic laboratories market, 2018 - 2030 (USD million)
Fig. 58 Physician offices market, 2018 - 2030 (USD million)
Fig. 59 Other end users market, 2018 - 2030 (USD million)
Fig. 60 Regional outlook, 2021 & 2030
Fig. 61 Regional marketplace: Key takeaways
Fig. 62 North America
Fig. 63 North America infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 64 U.S.
Fig. 65 U.S. infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 66 Canada
Fig. 67 Canada infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 68 Europe
Fig. 69 Europe infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 70 U.K.
Fig. 71 U.K. Infectious Respiratory Disease Diagnostics market, 2018 - 2030 (USD Million)
Fig. 72 Germany
Fig. 73 Germany infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 74 Spain
Fig. 75 Spain infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 76 France
Fig. 77 France infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 78 Italy
Fig. 79 Italy infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 80 Russia
Fig. 81 Russia infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 82 Asia Pacific
Fig. 83 Asia Pacific infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 84 Japan
Fig. 85 Japan infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 86 China
Fig. 87 China infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 88 India
Fig. 89 India infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 90 South Korea
Fig. 91 South Korea infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 92 Australia
Fig. 93 Australia infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 94 Singapore
Fig. 95 Singapore infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 96 Latin America
Fig. 97 Latin America infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 98 Brazil
Fig. 99 Brazil Infectious Respiratory Disease Diagnostics market, 2018 - 2030 (USD Million)
Fig. 100 Mexico
Fig. 101 Mexico infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 102 Argentina
Fig. 103 Argentina infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 104 Middle East and Africa
Fig. 105 MEA infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 106 South Africa
Fig. 107 South Africa infectious respiratory disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 108 Saudi Arabia
Fig. 109 Saudi Arabia Infectious Respiratory Disease Diagnostics market, 2018 - 2030 (USD Million)
Fig. 110 UAE
Fig. 111 UAE Infectious Respiratory Disease Diagnostics market, 2018 - 2030 (USD Million)
Fig. 112 Heat map analysis
Fig. 113 Company market position analysis (2021)
Fig. 114 Company market position analysis (2021)
Fig. 115 Company market position analysis (2021)
Fig. 116 Market differentiators
Fig. 117 Regional Network Map

Companies Mentioned

  • Abbott
  • Thermo Fisher Scientific, Inc.
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd
  • Biomérieux Sa
  • Bio-Rad Laboratories, Inc.
  • Quidel Corporation
  • Cepheid (Danaher)
  • Qiagen
  • Siemens Healthcare Gmbh

Methodology

Loading
LOADING...

Related Topics

Related Reports

Respiratory Diseases Diagnostic Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Respiratory Diseases Diagnostic Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 106 Pages
  • Global
From
Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 90 Pages
  • Global
From
Rapid Medical Diagnostic Kits Market Size, Share & Trends Analysis Report By Product (OTC Kits, Professional Kits), By Technology (Lateral Flow, Solid Phase), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Rapid Medical Diagnostic Kits Market Size, Share & Trends Analysis Report By Product (OTC Kits, Professional Kits), By Technology (Lateral Flow, Solid Phase), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 150 Pages
  • Global
From
Global Respiratory Infection Diagnostics Market by Test (Antigen Detection Assays, Direct Fluorescent Antibody Tests, Imaging Tests), Disease (Asthma, Chronic Obstructive Pulmonary Disease, Coronavirus Infections), End-User - Forecast 2024-2030 - Product Image

Global Respiratory Infection Diagnostics Market by Test (Antigen Detection Assays, Direct Fluorescent Antibody Tests, Imaging Tests), Disease (Asthma, Chronic Obstructive Pulmonary Disease, Coronavirus Infections), End-User - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Acute Care Syndromic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Acute Care Syndromic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 174 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.